Keywords: sb, requip, effective, restless, leg, syndrome, smithkline

SB's ReQuip effective in restless leg syndrome

Article | 11 May 2000

Print This

SmithKline Beecham's Parkinson's disease therapy ReQuip(ropinirole) is effective at low doses in treating restless-leg syndrome, say new data.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in